GLP1R and depressive symptom measurement: GLP-1 signaling has been shown to counteract key pathological processes such as oxidative stress, neuronal apoptosis, mitochondrial dysfunction, and neuroinflammation—all central contributors to conditions like AD, PD, stroke and depression.